Hyivy Health builds a medical-first pelvic rehab system that pairs a novel therapeutic device with an app and clinician portal to benchmark, monitor and treat pelvic pain. The technology is described as first-of-its-kind for measuring contributors and impact of pelvic pain in endometriosis patients and may help identify more than 51 conditions associated with pelvic pain, including cervical and ovarian cancers. Hyivy prioritized clinical validation and regulatory approval over a direct-to-consumer push and is conducting clinical trials addressing complex gynecological and colorectal patient populations. The company is preparing for U.S. market entry, starting rollout in California with over 25 clinics and actively recruiting additional gynecological and pelvic floor physiotherapy clinics. Hyivy is in the beginning stages of pursuing FDA approval. Founded in 2020 by Rachel Bartholomew following her cervical cancer diagnosis, the team says the product aims to make pelvic rehabilitation more gradual, manageable and clinically connected.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2024